Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households.

PubWeight™: 2.04‹?› | Rank: Top 2%

🔗 View Article (PMC 2364646)

Published in PLoS One on May 07, 2008

Authors

Benjamin J Cowling1, Rita O P Fung, Calvin K Y Cheng, Vicky J Fang, Kwok Hung Chan, Wing Hong Seto, Raymond Yung, Billy Chiu, Paco Lee, Timothy M Uyeki, Peter M Houck, J S Malik Peiris, Gabriel M Leung

Author Affiliations

1: Department of Community Medicine and School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Associated clinical trials:

A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households | NCT00425893

Articles citing this

Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med (2010) 5.90

Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010) 3.29

Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis (2009) 2.99

Influenza virus in human exhaled breath: an observational study. PLoS One (2008) 2.89

Estimation of the serial interval of influenza. Epidemiology (2009) 2.60

Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis (2010) 2.36

Models cannot predict future outbreaks: A/H1N1 virus, the paradigm. Eur J Epidemiol (2010) 1.86

Perceptions and behaviors related to hand hygiene for the prevention of H1N1 influenza transmission among Korean university students during the peak pandemic period. BMC Infect Dis (2010) 1.31

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One (2009) 1.30

Impact of non-pharmaceutical interventions on URIs and influenza in crowded, urban households. Public Health Rep (2010) 1.21

DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob Agents Chemother (2009) 1.18

Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS One (2010) 1.13

A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. Biostatistics (2009) 1.07

Optimal design of studies of influenza transmission in households. I: case-ascertained studies. Epidemiol Infect (2011) 0.93

Influenza transmission in a community during a seasonal influenza A(H3N2) outbreak (2010-2011) in Mongolia: a community-based prospective cohort study. PLoS One (2012) 0.90

Respiratory Infections in the U.S. Military: Recent Experience and Control. Clin Microbiol Rev (2015) 0.90

Influenza A Virus Shedding and Infectivity in Households. J Infect Dis (2015) 0.88

Airborne transmission of influenza: implications for control in healthcare and community settings. Clin Infect Dis (2012) 0.86

Impact of Intensive Handwashing Promotion on Secondary Household Influenza-Like Illness in Rural Bangladesh: Findings from a Randomized Controlled Trial. PLoS One (2015) 0.81

Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households. Am J Epidemiol (2015) 0.81

Prevention of influenza in healthy children. Expert Rev Anti Infect Ther (2012) 0.77

Optimal design of studies of influenza transmission in households. II: comparison between cohort and case-ascertained studies. Epidemiol Infect (2013) 0.77

Effect of the one-child policy on influenza transmission in China: a stochastic transmission model. PLoS One (2014) 0.77

Effectiveness of facemasks to reduce exposure hazards for airborne infections among general populations. J R Soc Interface (2011) 0.77

Protection by face masks against influenza A(H1N1)pdm09 virus on trans-Pacific passenger aircraft, 2009. Emerg Infect Dis (2013) 0.76

Household Transmission of Influenza Virus. Trends Microbiol (2015) 0.76

Fermented Milk Consumption and Common Infections in Children Attending Day-Care Centers: A Randomized Trial. J Pediatr Gastroenterol Nutr (2016) 0.75

Protective Effect of Hand-Washing and Good Hygienic Habits Against Seasonal Influenza: A Case-Control Study. Medicine (Baltimore) (2016) 0.75

Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness. BMJ Open (2016) 0.75

Articles cited by this

CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50

Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 14.59

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA (2000) 13.68

Avian influenza A (H5N1) infection in humans. N Engl J Med (2005) 12.95

The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine (2007) 9.96

Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis (2006) 6.85

Clinical signs and symptoms predicting influenza infection. Arch Intern Med (2000) 5.83

Review of aerosol transmission of influenza A virus. Emerg Infect Dis (2006) 5.31

Risk factors of influenza transmission in households. Br J Gen Pract (2004) 5.25

Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14

Does this patient have influenza? JAMA (2005) 4.53

Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis (2006) 4.34

Effectiveness of school-based influenza vaccination. N Engl J Med (2006) 4.06

Antiviral resistance and the control of pandemic influenza. PLoS Med (2007) 3.92

APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control (1995) 3.82

Effect of hand hygiene on infectious disease risk in the community setting: a meta-analysis. Am J Public Health (2008) 3.61

Controlling pandemic flu: the value of international air travel restrictions. PLoS One (2007) 3.59

Influenza-associated mortality in Hong Kong. Clin Infect Dis (2004) 3.02

Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health (2007) 2.90

Public health. Will vaccines be available for the next influenza pandemic? Science (2004) 2.74

Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong. Clin Infect Dis (2005) 2.53

Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis (1999) 2.49

Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med (2001) 2.34

Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ (2007) 2.33

Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol (2006) 2.19

Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J (2003) 2.15

Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg Infect Dis (2005) 2.04

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis (2002) 1.87

Clinical predictors of influenza in children. Arch Pediatr Adolesc Med (2004) 1.73

Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis (2006) 1.62

A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics (2005) 1.62

Public health. Next flu pandemic: what to do until the vaccine arrives? Science (2006) 1.46

Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev (2010) 1.18

Individual and community impact of influenza. Pharmacoeconomics (1999) 1.11

H5N1 avian influenza virus: an overview. Braz J Infect Dis (2007) 0.84

Articles by these authors

Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13

Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med (2005) 15.53

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21

Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59

Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02

Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52

Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52

Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell (2008) 6.37

Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80

Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med (2014) 5.74

Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med (2009) 5.68

Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32

Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 5.19

Catastrophic payments for health care in Asia. Health Econ (2007) 5.16

Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14

Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04

Lung pathology of fatal severe acute respiratory syndrome. Lancet (2003) 5.02

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00

Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis (2010) 4.81

Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis (2004) 4.40

Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A (2009) 4.36

Influenza-related hospitalizations among children in Hong Kong. N Engl J Med (2002) 4.30

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17

Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin Chem (2003) 4.03

Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet (2013) 3.90

Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med (2006) 3.86

Virology: SARS virus infection of cats and ferrets. Nature (2003) 3.86

Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77

Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem (2005) 3.75

Gain-of-function experiments on H7N9. Science (2013) 3.67

The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis (2010) 3.51

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 3.50

2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32

Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010) 3.29

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2002) 3.27

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis (2012) 3.19

Influenza-associated hospitalization in a subtropical city. PLoS Med (2006) 3.07

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med (2012) 3.05

Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. J Infect Dis (2009) 3.05

Influenza-associated mortality in Hong Kong. Clin Infect Dis (2004) 3.02

Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg (2005) 2.99

Low frequency of poultry-to-human H5NI virus transmission, southern Cambodia, 2005. Emerg Infect Dis (2006) 2.98

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2003) 2.96

Influenza virus in human exhaled breath: an observational study. PLoS One (2008) 2.89

Methods for monitoring influenza surveillance data. Int J Epidemiol (2006) 2.88

Real-time estimates in early detection of SARS. Emerg Infect Dis (2006) 2.87

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79

Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis (2006) 2.76

Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol (2010) 2.69

Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol (2008) 2.65

Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones. Chest (2007) 2.65

Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis (2011) 2.64

Estimation of the serial interval of influenza. Epidemiology (2009) 2.60

Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis (2009) 2.60

Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57

Who pays for health care in Asia? J Health Econ (2007) 2.53

Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51

Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg (2005) 2.50

Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis (2009) 2.50

Evolving complexities of influenza virus and its receptors. Trends Microbiol (2008) 2.49

Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48

Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med (2010) 2.47

Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res (2007) 2.45

Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci (2004) 2.45